Corona Remedies Ltd IPO – Dates, Price Band & Lot Size
The Corona Remedies Ltd IPO will be live from 08 Dec'25 to 10 Dec'25 with an issue size of ₹655.37 crores. The IPO is priced in the band of ₹0.00–₹1062.00 per share with a minimum lot size of 14.00 shares. Stay updated with IPO dates, allotment status, and listing details.
Min Investment ₹14868.00
Subscribed Times 137.04x
Issues size ₹655 Crores
Price Range ₹0.00 - ₹1062.00
Open on 08 Dec'25
Close on 10 Dec'25
Corona Remedies Ltd IPO Details
Lot Size 14.00
Issue size ₹655 Crores
Issue Type Book Building
Corona Remedies Ltd Shares Offered
Qualified Inst. Buyers 28.19
Non Inst. Buyers 21.14
Retails Ind. Buyers 49.33
Corona Remedies Ltd Subscription Status
(as of 14 Jan 2026) Overall Status 137.04x
Qualified Inst. Buyers 278.52x
Non Inst. Buyers 208.88x
Retails Ind. Buyers 28.73x
Corona Remedies Ltd IPO Timeline
08 Dec'25 Issue Open
10 Dec'25 Issue Close
11 Dec'25 Finalization of Basis of Allotment
12 Dec'25 Initiation of refund
12 Dec'25 Transfer of shares to Demat Account
15 Dec'25 Listing Date
Corona Remedies Ltd Objects of the offer
Further increase our market share within the domestic Indian pharmaceutical market.
Grow our product portfolio with a focus on long product life cycles and progression.
Expand into other therapeutic areas with significant growth potential and deepen our presence in existingtherapeutic areas.
Execute strategic acquisitions and establish in-licensing agreements.
Expand our sales in select overseas markets with a focused approach.
Corona Remedies Ltd Company's Financials
Assets(cr) Mar 2025 731.19 Mar 2024 671.41 Mar 2023 461.78
Gross Profit(cr) Mar 2025 235.69 Mar 2024 146.76 Mar 2023 130.99
Liabilities(cr) Mar 2025 124.85 Mar 2024 191.00 Mar 2023 53.26
Net Income(cr) Mar 2025 149.43 Mar 2024 90.50 Mar 2023 84.93
Revenue(cr) Mar 2025 1196.42 Mar 2024 1014.47 Mar 2023 884.05
Corona Remedies Ltd Peer Comparison
Script Name Corona Remedies Ltd Revenue(cr) 1196.42 Net Profit(cr) 149.43 EPS 24.43 Current Ratio 1.63
Script Name Abbott India Ltd Revenue(cr) 6409.15 Net Profit(cr) 1414.44 EPS 665.62 Current Ratio 23.90
Script Name Alkem Laboratories Ltd Revenue(cr) 12964.50 Net Profit(cr) 2165.48 EPS 181.11 Current Ratio 12.24
Script Name ERIS Lifesciences Ltd Revenue(cr) 2893.64 Net Profit(cr) 351.84 EPS 25.81 Current Ratio 5.00
Script Name Glaxosmithkline Pharmaceuticals Ltd Revenue(cr) 3749.21 Net Profit(cr) 930.24 EPS 54.76 Current Ratio 22.64
Script Name J B Chemicals & Pharmaceuticals Ltd Revenue(cr) 3917.99 Net Profit(cr) 659.58 EPS 41.56 Current Ratio 15.43
Script Name Mankind Pharma Ltd Revenue(cr) 12207.40 Net Profit(cr) 1990.96 EPS 49.20 Current Ratio 7.17
Script Name Pfizer Ltd Revenue(cr) 2281.35 Net Profit(cr) 767.60 EPS 136.46 Current Ratio 15.62
Script Name Torrent Pharmaceuticals Ltd Revenue(cr) 11516.10 Net Profit(cr) 1911.25 EPS 56.47 Current Ratio 12.75
Corona Remedies Ltd IPO
Corona Remedies Ltd Company Contact Info
Corona House C-Mondeal Busines,
-Park S.G.Highway Thaltej,
Ahmedabad-380059
Phone : +91 79 4023 3000
Corona Remedies Ltd Registrar & Transfer Agent
Bigshare Services Pvt Ltd
Office No S6-2,
Pinnacle Busine.Park-Mumbai - 400093
Phone : 91-22-62638200
Fax : 91-22-63638299
Corona Remedies Ltd Book Running Managers
Offer Related Information
Initial public offering of 6,174,051 equity shares of face value of Rs.10/- each (equity shares) of Corona Remedies Limited (company) for cash at a price of Rs.1,062/- per equity share (offer price) aggregating to Rs.655.37 crores (offer), comprising an offer for sale of 1,223,193 equity shares offace value of Rs.10/- each aggregating to Rs.129.84 crores by Kirtikumar Laxmidas Mehta (promoter selling sharheolder), 721,691 equity shares of face value of Rs.10/- each aggregating to Rs.76.61 crores by Minaxi Kirtikumar Mehta, 97,853 equity shares of face value of Rs.10/- each aggregating to Rs.10.39 crores by Dipabahen Niravkumar Mehta, 97,853 equity shares of face value of Rs.10/- each aggregating to Rs.10.39 crores by Brinda Ankur Mehta (promoter group selling shareholders), 3,811,613 equity shares of face value of Rs.10/- each aggregating to Rs.404.60 crores by Sepia Investments Limited, 142,488 equity shares of face value of Rs.10/- each aggregating to Rs.15.13 crores by Anchor Partners and 79,360 equity shares of face value of Rs.10/- each aggregating to Rs.8.42 crores by Sage Investment Trust (investor selling shareholders, and along with the promoter selling shareholder and promoter group selling shareholders, the selling shareholders) (offer for sale, and such equity shares offered in the offer for sale, the offered shares).
Corona Remedies Ltd IPO FAQs
What is the issue size of Corona Remedies Ltd IPO?
The issue size of Corona Remedies Ltd IPO is ₹ 655 crore.
What is 'pre-apply' for Corona Remedies Ltd IPO?
'Pre-apply' lets you place your IPO application before the official opening date.
If I pre-apply for Corona Remedies Ltd IPO, when will my order get placed?
Your order will be placed automatically once the IPO opens for subscription.
When will I know if my Corona Remedies Ltd IPO order is placed?
You'll get a confirmation via SMS/email once your IPO order is successfully placed.
What are the open and close dates of the Corona Remedies Ltd IPO?
The IPO opens on 08 Dec and closes on 10 Dec.
What is the lot size and minimum order quantity of the Corona Remedies Ltd IPO?
The minimum order is 1 lot, which consists of 14.00 shares.
What is the allotment date for the Corona Remedies Ltd IPO?
The allotment is expected on 11 Dec.
Who is the registrar of the Corona Remedies Ltd IPO?
Bigshare Services Pvt Ltd is the registrar for this IPO.
Where is the Corona Remedies Ltd IPO getting listed?
It will be listed on BSE,NSE.